Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 362158, 13 pages
http://dx.doi.org/10.1155/2015/362158
Research Article

Nephroprotective Effects of Polydatin against Ischemia/Reperfusion Injury: A Role for the PI3K/Akt Signal Pathway

1Department of Nephrology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, China
2State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi’an 710032, China
3Institute of Materia Medica, School of Pharmacy, Fourth Military Medical University, Xi’an 710032, China

Received 22 November 2014; Accepted 30 January 2015

Academic Editor: Matías Mosqueira

Copyright © 2015 Hong-Bao Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Liu, S. Liu, Y. Li et al., “The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury,” PloS ONE, vol. 7, no. 4, Article ID e34608, 2012. View at Google Scholar · View at Scopus
  2. M. Yoshida and S. Honma, “Regeneration of injured renal tubules,” Journal of Pharmacological Sciences, vol. 124, no. 2, pp. 117–122, 2014. View at Publisher · View at Google Scholar
  3. R. Munshi, C. Hsu, and J. Himmelfarb, “Advances in understanding ischemic acute kidney injury,” BMC Medicine, vol. 9, article 11, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. Q.-H. Du, C. Peng, and H. Zhang, “Polydatin: a review of pharmacology and pharmacokinetics,” Pharmaceutical Biology, vol. 51, no. 11, pp. 1347–1354, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. Q. Miao, S. Wang, S. Miao, J. Wang, Y. Xie, and Q. Yang, “Cardioprotective effect of polydatin against ischemia/reperfusion injury: roles of protein kinase C and mito K(ATP) activation,” Phytomedicine, vol. 19, no. 1, pp. 8–12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Huang, C. Chen, J. Hao et al., “Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-β1 in rat glomerular messangial cells,” Molecular and Cellular Endocrinology, vol. 399, pp. 178–189, 2015. View at Publisher · View at Google Scholar
  7. X. Xie, J. Peng, K. Huang et al., “Polydatin ameliorates experimental diabetes-induced fibronectin through inhibiting the activation of NF-kappaB signaling pathway in rat glomerular mesangial cells,” Molecular and Cellular Endocrinology, vol. 362, no. 1-2, pp. 183–193, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. Y.-W. Shi, C.-P. Wang, L. Liu et al., “Antihyperuricemic and nephroprotective effects of resveratrol and its analogues in hyperuricemic mice,” Molecular Nutrition and Food Research, vol. 56, no. 9, pp. 1433–1444, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Chen, Z. Lan, Q. Lin et al., “Polydatin ameliorates renal injury by attenuating oxidative stress-related inflammatory responses in fructose-induced urate nephropathic mice,” Food and Chemical Toxicology, vol. 52, pp. 28–35, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Barthel and L. O. Klotz, “Phosphoinositide 3-kinase signaling in the cellular response to oxidative stress,” Biological Chemistry, vol. 386, no. 3, pp. 207–216, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. L. C. Cantley, “The phosphoinositide 3-kinase pathway,” Science, vol. 296, no. 5573, pp. 1655–1657, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Liu, W. Xue, G. Ge et al., “Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1alpha in MSCs,” Biochemical and Biophysical Research Communications, vol. 401, no. 4, pp. 509–515, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. D. S. Kwon, C. H. Kwon, J. H. Kim, J. S. Woo, J. S. Jung, and Y. K. Kim, “Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells,” European Journal of Cell Biology, vol. 85, no. 11, pp. 1189–1199, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. W.-H. Liu, H.-B. Liu, D.-K. Gao et al., “ABCG2 protects kidney side population cells from hypoxia/reoxygenation injury through activation of the MEK/ERK pathway,” Cell Transplantation, vol. 22, no. 10, pp. 1859–1868, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Liu, W. Liu, S. Liu et al., “Reconstitution of kidney side population cells after ischemia-reperfusion injury by self-proliferation and bone marrow-derived cell homing,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 370961, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. H. B. Liu, Q. H. Meng, D. W. Du, J. F. Sun, J. B. Wang, and H. Han, “The effects of ABCG2 on the viability, proliferation and paracrine actions of kidney side population cells under oxygen-glucose deprivation,” International Journal of Medical Sciences, vol. 11, no. 10, pp. 1001–1008, 2014. View at Publisher · View at Google Scholar
  17. G. Lanzilli, A. Cottarelli, G. Nicotera, S. Guida, G. Ravagnan, and M. P. Fuggetta, “Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation,” Inflammation, vol. 35, no. 1, pp. 240–248, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. L. T. Liu, G. Guo, M. Wu, and W. G. Zhang, “The progress of the research on cardio-vascular effects and acting mechanism of polydatin,” Chinese Journal of Integrative Medicine, vol. 18, no. 9, pp. 714–719, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Cheng, H.-T. Zhang, L. Sun et al., “Involvement of cell adhesion molecules in polydatin protection of brain tissues from ischemia-reperfusion injury,” Brain Research, vol. 1110, no. 1, pp. 193–200, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Sun, Y. Qu, H. He et al., “Protective effect of polydatin on learning and memory impairments in neonatal rats with hypoxicischemic brain injury by upregulating brainderived neurotrophic factor,” Molecular Medicine Reports, vol. 10, no. 6, pp. 3047–3051, 2014. View at Google Scholar
  21. M. Kitada and D. Koya, “Renal protective effects of resveratrol,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 568093, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. J. V. Bonventre and A. Zuk, “Ischemic acute renal failure: an inflammatory disease?” Kidney International, vol. 66, no. 2, pp. 480–485, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. H. R. Jang and H. Rabb, “Immune cells in experimental acute kidney injury,” Nature Reviews Nephrology, vol. 11, no. 2, pp. 88–101, 2014. View at Publisher · View at Google Scholar
  24. A. Akcay, Q. Nguyen, and C. L. Edelstein, “Mediators of inflammation in acute kidney injury,” Mediators of Inflammation, vol. 2009, Article ID 137072, 12 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. E. Sabbahy and V. S. Vaidya, “Ischemic kidney injury and mechanisms of tissue repair,” Wiley Interdisciplinary Reviews: Systems Biology and Medicine, vol. 3, no. 5, pp. 606–618, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. C. Brøchner, F. Dagnæs-Hansen, J. Højberg-Holm, and P. Toft, “The inflammatory response in blood and in remote organs following acute kidney injury,” APMIS, vol. 122, no. 5, pp. 399–404, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Grenz, J.-H. Kim, J. D. Bauerle, E. Tak, H. K. Eltzschig, and E. T. Clambey, “Adora2b adenosine receptor signaling protects during acute kidney injury via inhibition of neutrophil-dependent TNF-α release,” Journal of Immunology, vol. 189, no. 9, pp. 4566–4573, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Y. Chen, C. H. Yeh, E. C. So, D. P. Sun, L. Y. Wang, and C. H. Hsing, “Anticancer drug 2-methoxyestradiol protects against renal ischemia/reperfusion injury by reducing inflammatory cytokines expression,” BioMed Research International, vol. 2014, Article ID 431524, 11 pages, 2014. View at Publisher · View at Google Scholar
  29. U. Aksu, I. Guner, O. M. Yaman et al., “Fluoxetine ameliorates imbalance of redox homeostasis and inflammation in an acute kidney injury model,” Journal of Physiology and Biochemistry, vol. 70, no. 4, pp. 925–934, 2014. View at Publisher · View at Google Scholar
  30. S. Ye, Y. Zhu, Y. Ming, X. She, H. Liu, and Q. Ye, “Glycyrrhizin protects mice against renal ischemia-reperfusion injury through inhibition of apoptosis and inflammation by downregulating p38 mitogen-activated protein kinase signaling,” Experimental and Therapeutic Medicine, vol. 7, no. 5, pp. 1247–1252, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Candelario-Jalil and B. L. Fiebich, “Cyclooxygenase inhibition in ischemic brain injury,” Current Pharmaceutical Design, vol. 14, no. 14, pp. 1401–1418, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Q. Feitoza, N. O. S. Câmara, H. S. Pinheiro et al., “Cyclooxygenase 1 and/or 2 blockade ameliorates the renal tissue damage triggered by ischemia and reperfusion injury,” International Immunopharmacology, vol. 5, no. 1, pp. 79–84, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Hauser, G. Fröba, H. Bracht et al., “Effects of intrarenal administration of the cox-2 inhibitor parecoxib during porcine suprarenal aortic cross-clamping,” Shock, vol. 24, no. 5, pp. 476–481, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. Z. Miloradovic, N. Mihailović-Stanojević, J. G. Milanović, M. Ivanov, M. Jerkić, and D. Jovović, “Nitric oxide supplementation in postischemic acute renal failure: normotension versus hypertension,” Current Pharmaceutical Biotechnology, vol. 12, no. 9, pp. 1364–1367, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Rodriguez, B. Bonacasa, F. J. Fenoy, and M. G. Salom, “Reactive oxygen and nitrogen species in the renal ischemia/reperfusion injury,” Current Pharmaceutical Design, vol. 19, no. 15, pp. 2776–2794, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Korkmaz and D. Kolankaya, “Inhibiting inducible nitric oxide synthase with rutin reduces renal ischemia/reperfusion injury,” Canadian Journal of Surgery, vol. 56, no. 1, pp. 6–14, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. L. A. Mark, A. V. Robinson, and J. A. Schulak, “Inhibition of nitric oxide synthase reduces renal ischemia/reperfusion injury,” Journal of Surgical Research, vol. 129, no. 2, pp. 236–241, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. P. K. Chatterjee, N. S. A. Patel, E. O. Kvale et al., “Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury,” Kidney International, vol. 61, no. 3, pp. 862–871, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Jin, Z. Song, S. Yu et al., “Phosphatidylinositol-3-kinase gamma plays a central role in blood-brain barrier dysfunction in acute experimental stroke,” Stroke, vol. 42, no. 7, pp. 2033–2044, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Hu, X. Huang, K. Zhang, H. Jiang, and X. Hu, “Anti-inflammatory effect of B-type natriuretic peptide postconditioning during myocardial ischemia-reperfusion: involvement of PI3K/Akt signaling pathway,” Inflammation, vol. 37, no. 5, pp. 1669–1674, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Yuan, S. Jing, L. Wu, L. Chen, and J. Fang, “Pharmacological postconditioning with tanshinone IIA attenuates myocardial ischemia-reperfusion injury in rats by activating the phosphatidylinositol 3-kinase pathway,” Experimental and Therapeutic Medicine, vol. 8, no. 3, pp. 973–977, 2014. View at Publisher · View at Google Scholar
  42. W. Chen, G. Zheng, S. Yang et al., “CYP2J2 and EETs protect against oxidative stress and apoptosis in vivo and in vitro following lung ischemia/reperfusion,” Cellular Physiology and Biochemistry, vol. 33, no. 6, pp. 1663–1680, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. H. J. Kim, Y. Joe, J. S. Kong et al., “Carbon monoxide protects against hepatic ischemia/reperfusion injury via ROS-dependent Akt signaling and inhibition of glycogen synthase kinase 3beta,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 306421, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. E. A. El Eter and A. Aldrees, “Inhibition of proinflammatory cytokines by SCH79797, a selective protease-activated receptor 1 antagonist, protects rat kidney against ischemia-reperfusion injury,” Shock, vol. 37, no. 6, pp. 639–644, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. Q. Zhang, Y. Tan, N. Zhang, and F. Yao, “Polydatin supplementation ameliorates diet-induced development of insulin resistance and hepatic steatosis in rats,” Molecular Medicine Reports, vol. 11, no. 1, pp. 603–610, 2014. View at Publisher · View at Google Scholar
  46. J. Hao, C. Chen, K. Huang et al., “Polydatin improves glucose and lipid metabolism in experimental diabetes through activating the Akt signaling pathway,” European Journal of Pharmacology, vol. 745, pp. 152–165, 2014. View at Publisher · View at Google Scholar
  47. H. Liu, S. Zhao, Y. Zhang et al., “Reactive oxygen species-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to polydatin-induced apoptosis in human nasopharyngeal carcinoma CNE cells,” Journal of Cellular Biochemistry, vol. 112, no. 12, pp. 3695–3703, 2011. View at Publisher · View at Google Scholar · View at Scopus